✦ LIBER ✦

70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With Gastroparesis

✍ Scribed by Barton, Matthew E.; Otiker, Tal; Johnson, Lakshmi Vasist; Robertson, Darren C.; Dobbins, Robert L.; Parkman, Henry P.; Hellström, Per M.; Tack, Jan F.; Kuo, Braden; Hobson, Anthony; Dukes, George E.

Book ID: 122193370
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 218 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)60070-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

929a A Phase 2, Randomized, Double-blind

929a A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 in Patients with Diabetic Gastroparesis

✍ Lembo, Anthony; Camilleri, Michael; McCallum, Richard W.; Sastre, Ramon F.; Bret 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 170 KB

A Double-Blind, Randomized Placebo-Contr

A Double-Blind, Randomized Placebo-Controlled Phase II Study of the Pharmacodynamics, Safety/Tolerability, and Pharmacokinetics of Single Doses of the Motilin Agonist GSK962040, in Patients With Type I Diabetes Mellitus (T1DM) and Gastroparesis

✍ Hellström, Per M. ;Tack, Jan F. ;Stephens, Kimberley E. ;Barton, Matthew E. ;Vas 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 102 KB

A double blind, randomized, placebo-cont

A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS

✍ Mark Holodniy; Johannes Koch; Mark Mistal M.S.N; Jamey Maimares Schmidt R.D; Atu 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Evaluation of the Safety and Efficacy of

Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study

✍ Mohammad Reza Safarinejad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

A phase 2, double-blind, randomized, pla

A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation

✍ Webster, Lynn; Dhar, Sunita; Eldon, Michael; Masuoka, Lorianne; Lappalainen, Jaa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 320 KB

A multicenter, randomized, placebo-contr

A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

✍ E. J. Rhee; W. Y. Lee; K. H. Yoon; S. J. Yoo; I. K. Lee; S. H. Baik; Y. K. Kim; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB